Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C.

Source:http://linkedlifedata.com/resource/pubmed/id/14638334

Download in:

View as

General Info

PMID
14638334